These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 33960710)
21. Liquid biopsy in germ cell tumors: biology and clinical management. Chovanec M; Kalavska K; Mego M; Cheng L Expert Rev Mol Diagn; 2020 Feb; 20(2):187-194. PubMed ID: 31652083 [No Abstract] [Full Text] [Related]
22. [Treatment principle and surgical technique of pulmonary ground glass nodules]. Wang Q; Jiang W; Wang L; Xi JJ Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):6-9. PubMed ID: 30678410 [TBL] [Abstract][Full Text] [Related]
23. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram. Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097 [TBL] [Abstract][Full Text] [Related]
24. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA. Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536 [TBL] [Abstract][Full Text] [Related]
25. Evolving the pulmonary nodules diagnosis from classical approaches to deep learning-aided decision support: three decades' development course and future prospect. Liu B; Chi W; Li X; Li P; Liang W; Liu H; Wang W; He J J Cancer Res Clin Oncol; 2020 Jan; 146(1):153-185. PubMed ID: 31786740 [TBL] [Abstract][Full Text] [Related]
26. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
27. DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients. Schotten LM; Darwiche K; Seweryn M; Yildiz V; Kneuertz PJ; Eberhardt WEE; Eisenmann S; Welter S; Sisson BE; Pietrzak M; Wiesweg M; Ploenes T; Hager T; He K; Freitag L; Aigner C; Taube C; Oezkan F Eur J Cancer; 2021 Apr; 147():142-150. PubMed ID: 33662689 [TBL] [Abstract][Full Text] [Related]
28. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823 [TBL] [Abstract][Full Text] [Related]
29. Whole Exome Sequencing of Cell-Free DNA for Early Lung Cancer: A Pilot Study to Differentiate Benign From Malignant CT-Detected Pulmonary Lesions. Tailor TD; Rao X; Campa MJ; Wang J; Gregory SG; Patz EF Front Oncol; 2019; 9():317. PubMed ID: 31069172 [No Abstract] [Full Text] [Related]
30. Plasma Cell-Free DNA to Differentiate Malignant from Benign Thyroid Nodules. Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S J Clin Endocrinol Metab; 2021 Apr; 106(5):e2262-e2270. PubMed ID: 33475693 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review. Cervena K; Vodicka P; Vymetalkova V Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571 [TBL] [Abstract][Full Text] [Related]
32. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application. Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662 [TBL] [Abstract][Full Text] [Related]
33. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA. Zeng H; He B; Yi C; Peng J J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556 [TBL] [Abstract][Full Text] [Related]
34. Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules. Paez R; Kammer MN; Tanner NT; Shojaee S; Heideman BE; Peikert T; Balbach ML; Iams WT; Ning B; Lenburg ME; Mallow C; Yarmus L; Fong KM; Deppen S; Grogan EL; Maldonado F Chest; 2023 Oct; 164(4):1028-1041. PubMed ID: 37244587 [TBL] [Abstract][Full Text] [Related]
35. Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers. Hofman P Cancer Cytopathol; 2021 May; 129(5):341-346. PubMed ID: 33007153 [TBL] [Abstract][Full Text] [Related]
36. Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features. Xu L; Chang N; Yang T; Lang Y; Zhang Y; Che Y; Xi H; Zhang W; Song Q; Zhou Y; Yang X; Yang J; Qu S; Zhang J Front Oncol; 2022; 12():883543. PubMed ID: 35530343 [TBL] [Abstract][Full Text] [Related]
37. Urine-Based Liquid Biopsy for Nonurological Cancers. Jain S; Lin SY; Song W; Su YH Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103 [TBL] [Abstract][Full Text] [Related]
38. Computer-aided diagnosis of lung cancer: the effect of training data sets on classification accuracy of lung nodules. Gong J; Liu JY; Sun XW; Zheng B; Nie SD Phys Med Biol; 2018 Feb; 63(3):035036. PubMed ID: 29311420 [TBL] [Abstract][Full Text] [Related]
39. Emerging on-chip electrokinetic based technologies for purification of circulating cancer biomarkers towards liquid biopsy: A review. Shi L; Esfandiari L Electrophoresis; 2022 Jan; 43(1-2):288-308. PubMed ID: 34791687 [TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy approach in the management of prostate cancer. Riaz IB; Wang L; Kohli M Transl Res; 2018 Nov; 201():60-70. PubMed ID: 29936077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]